Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding

Author(s):  Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel

Issue:  Jul/Aug 2009 - Homone Replacement Therapy
View All Articles in Issue

Page(s):  314-317

Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Page 1
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Page 2
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Page 3
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Page 4

Download in electronic PDF format for $75

Abstract:  This article is an adaptation of an abstract/poster presentation made at the 13th Annual International Congress on Steroidal Hormones and Hormones & Cancer, Quebec City, Canada (September 2008), concerning the topic of breast feeding as a contraindication to testosterone therapy. The purpose of the presentation and this article is to provide a summary of the findings of a study that was conducted to evaluate maternal absorption of testosterone and its excretion into breast milk by using three methods of delivery: sublingual drops, vaginal cream, and pellet implant. Testosterone was measurable in maternal blood by all three methods of delivery. No significant increase of testosterone was seen in breast milk when testosterone was delivered by vaginal cream, sublingual drops, of subcutaneous pellet implant. Testosterone was very low in infant blood at baseline and during testosterone therapy by pellet implant. There were no adverse clinical effects in the infant after seven months of continuous testosterone ther

Related Keywords: Rebecca L. Glaser, MD, FACS, Mark Newman, MS, Melanie Parsons, MASc, David Zava, PhD, Daniel Glaser-Garbrick, breast feeding, infants, androgen deficiency, testosterone, breast milk, route of administration, hormone replacement therapy, HRT, pellet implant, sublingual drops, vaginal cream, capillary bloodspot, estradiol, absorption

Related Categories: HRT, PEDIATRICS, ADVERSE DRUG EVENTS, DOSAGE FORMS/DRUG CARRIERS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, PATIENT ASSESSMENT

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding
Glaser Rebecca L
, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
Jul/Aug 2009
Pg. 314-317

Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1
Cutter Christopher B
Jan/Feb 2004
Pg. 16-21

Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy
Glaser Rebecca L
, York Anne E
Jul/Aug 2019
Pg. 325-339

Recommendations for Compounding Medications for Feeding Tube Administration
Klang Mark
Jul/Aug 2010
Pg. 276-282

Testosterone Deficiency in Men: New Treatments for Andropause
Biundo Bruce
, Shippen Eugene
Nov/Dec 2000
Pg. 429-431

Testosterone Replacement Therapy for Female Androgen Insufficiency Syndrome
Tan Robert S
Jul/Aug 2005
Pg. 259-264

View Sample
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review
Ruiz Andres D
, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
Jul/Aug 2011
Pg. 290-300

Testosterone Levels in an Aging Population: Screen, Measure, and Restore
Kells John
, DollbaumCharles M
Mar/Apr 2011
Pg. 102-112

Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists
Cutter Christopher B
Nov/Dec 2000
Pg. 432-437

View Sample
Testosterone Cypionate 100-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 73

Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 2
Cutter Christopher B
Mar/Apr 2004
Pg. 96-99

Compounded Testosterone Troches to optimize Health and the Testosterone Controversy
Guth Michael AS
May/Jun 2015
Pg. 195-203

Case Reports: Steroid Substitute Treatment for Psoriasis; Metronidazole for Odor Related to Untreated Metastatic Breast Tumor
Mason Dave
Jan/Feb 1999
Pg. 34-35

The Hormonal Link to Breast Cancer: The Estrogen Matrix
Zava David T
Jul/Aug 2002
Pg. 250-254

Case Study: Absorption of Testosterone Cream via Scrotal Delivery
Needham Shawn
, Needham Shane
Nov/Dec 2018
Pg. 466-468

Testosterone Enanthate 200-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 151

Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Allen W Chris
, Greeson Nicole MH, Mixon William
Nov/Dec 2020
Pg. 451-458

Bioidentical Hormone Replacement Therapy, Part 3, A Review of
Wepfer Scott T
Mar/Apr 2002
Pg. 142-146

Measuring Testosterone Biomarkers in Serum and Saliva: Are They Accurate?
Tan Robert S
Nov/Dec 2004
Pg. 419-423

Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration
de Villiers Melgardt M
, Vogel Laura, Bogenschutz Monica C, Fingerhut Bonnie J, D'Silva Joseph B, Moore Anne
May/Jun 2010
Pg. 250-256

Return to Top